ACHV · Insider trading · 13F holders · Congress trades
Achieve Life Sciences, Inc. (ACHV)
Who is buying and selling ACHV: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 12
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $175K
- Congress trades, 12 months
- 0
ACHV at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 ACHV insider filed 1 sale worth $175K on SEC Form 4, and no open-market purchases.
- 12 13F filers hold ACHV among their 50 largest positions, worth $278.8M combined. The biggest bets by portfolio weight are Propel Bio Management, LLC (13.8%), KVP Capital Advisors, LP (2.2%) and Vivo Capital, LLC (1.6%). In their latest 13Fs, 7 managers opened a new position and 1 added to one.
- No member of Congress has disclosed a trade in ACHV.
- ACHV last closed at $7.19 on Oct 29, 2026.
ACHV insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 ACHV insider filed 1 sale worth $175K on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Stewart Richard Alistair | Director | Sale | 20,626 | $8.49 | $175K | SEC |
Who owns ACHV? Hedge funds and superinvestors
12 13F filers hold ACHV among their 50 largest positions, worth $278.8M combined. The biggest bets by portfolio weight are Propel Bio Management, LLC (13.8%), KVP Capital Advisors, LP (2.2%) and Vivo Capital, LLC (1.6%). In their latest 13Fs, 7 managers opened a new position and 1 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P.Hedge fund | 1.1% | $49.7M | 7,614,836 | New | Q2 2026 |
| Tpg Gp A, LLCInvestment manager | 0.9% | $44.9M | 6,877,580 | — | Q2 2026 |
| venBio Partners LLCHedge fund | 7.4% | $38.6M | 5,914,720 | New | Q2 2026 |
| Logos Global Management LPHedge fund | 1.5% | $35.4M | 5,425,000 | — | Q2 2026 |
| Paradigm Biocapital Advisors LPHedge fund | 0.6% | $32.3M | 4,951,856 | New | Q2 2026 |
| Propel Bio Management, LLCHedge fund | 13.8% | $26.3M | 4,034,018 | +6.5% shares | Q2 2026 |
| Vivo Capital, LLCHedge fund | 1.6% | $18.0M | 2,751,032 | New | Q2 2026 |
| Venrock Adviser, LLCHedge fund | 0.5% | $18.0M | 2,751,032 | New | Q2 2026 |
| Simplify Asset Management Inc.Mutual fund manager | 0.1% | $7.5M | 932,105 | -34.9% shares | Q3 2026 |
| Spruce Street Capital LPHedge fund | 0.9% | $4.8M | 736,637 | New | Q2 2026 |
| KVP Capital Advisors, LPHedge fund | 2.2% | $3.0M | 462,355 | +0.0% shares | Q2 2026 |
| Jones Hill Capital LPHedge fund | 0.0% | $175K | 26,760 | New | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 11). Screen ACHV in the grand portfolio →
ACHV stock trades by members of Congress
No member of Congress has disclosed a trade in ACHV.
ACHV questions and answers
Are insiders buying ACHV stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 ACHV insider filed 1 sale worth $175K on SEC Form 4, and no open-market purchases.
Which hedge funds own ACHV?
12 13F filers hold ACHV among their 50 largest positions, worth $278.8M combined. The biggest bets by portfolio weight are Propel Bio Management, LLC (13.8%), KVP Capital Advisors, LP (2.2%) and Vivo Capital, LLC (1.6%). In their latest 13Fs, 7 managers opened a new position and 1 added to one.
Has Congress traded ACHV?
No member of Congress has disclosed a trade in ACHV.
Who is the largest holder of ACHV?
Among 13F filers, Frazier Life Sciences Management, L.P. reports the largest ACHV position, $49.7M (7,614,836 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Propel Bio Management, LLC's: 13.8% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.